«上一篇/Previous Article|本期目录/Table of Contents|下一篇/Next Article»

《天津医科大学学报》[ISSN:1006-8147/CN:12-1259/R]

卷:

26卷

期数:

2020年01期

页码:

56-60,67

栏目:

临床医学

出版日期:

2020-04-06

文章信息/Info

Title:

Risk factors of complicated coronary artery lesion in Kawasaki disease

文章编号:

1006-8147(2020)01-0056-05

作者:

王 茜; 周宇辉; 王雨婷; 郑荣秀

（天津医科大学总医院儿科，天津 300052）

Author(s):

WANG Xi;  ZHOU Yu-hui;  WANG Yu-ting;  ZHENG Rong-xiu

（Department of Pediatrics, General Hospital，Tianjin Medical University, Tianjin 300052, China）

关键词:

川崎病;  冠状动脉扩张;  危险因素; 血小板/淋巴细胞比值

Keywords:

Kawasaki disease; coronary artery lesion ; risk factors; platelet-to-lymphocyte ratio

分类号:

R725.4

DOI:

-

文献标志码:

A

摘要:

目的：探究川崎病（KD）并发冠状动脉损害(CAL)的危险因素。方法：选择2016年2月-2018年11月于天津医科大学总医院住院治疗的91例川崎病患儿的临床资料为研究对象，并按照超声心动图结果将其分为CAL组（KD并发CAL，n=23）和NCAL组（KD未并发CAL，n=68）。将两组的性别、年龄、主要诊断、发热持续时间、血红蛋白（HB）、中性粒细胞/淋巴细胞比值（NLR）、血小板/淋巴细胞比值（PLR）、血小板/中性粒细胞比值（PNR）、血钠、总蛋白、白蛋白、谷草转氨酶、谷丙转氨酶、血沉（ESR）、C反应蛋白（CRP）、降钙素原（PCT）、N端脑钠肽前体（NT-proBNP）、静脉注射用免疫球蛋白（IVIG）及阿司匹林的初始治疗、是否应用激素进行单因素分析及二元Logistic回归分析。结果：两组患儿年龄、PLR、HB、PCT、ESR、IVIG无反应的发生，差异有统计学意义（P＜0.05）。二元Logistic回归分析结果显示，年龄、PLR及HB是川崎病并发冠状动脉扩张的危险因素（P＜0.05）。结论：患儿年龄小、PLR升高及HB降低是KD并发CAL的独立危险因素。

Abstract:

Objective: To investigate the risk factors of complicated coronary artery lesion(CAL) in Kawasaki disease(KD). Methods: The clinical data of 91 patients with Kawasaki disease who were hospitalized at the General Hospital of Tianjin Medical University from February 2016 to November 2018 were selected as the subjects, and they were divided into CAL group(KD complicated CAL, n =23) and NCAL group(KD not complicated CAL, n= 68) according to echocardiogram results. Their gender, age, main diagnosis, duration of fever, Hemoglobin(HB), neutrophil-to-lymphocyte ratio(NLR), platelet-to-lymphocyte ratio(PLR), platelet-to-neutrophil ratio(PNR), blood Sodium, Total protein, Albumin, Aspartate aminotransferase, Alanine aminotransferase, Erythrocyte sedimentation rate(ESR), C-reactive protein(CRP), Procalcitonin (PCT), N-terminal pro-brain natriuretic peptide (NT-proBNP), the initial treatment of Intravenous immune globulin(IVIG) and aspirin, Whether hormone was used were compared between the two groups by single factor analysis and binary logistic regression analysis. Results: There were significant differences in age, PLR, HB, PCT, ESR and the occurrence of non-reactivity of IVIG between the two groups(P＜0.05). The results of binary logistic regression analysis showed that age, PLR, and HB are risk factors of complicated CAL in KD(P＜0.05). Conclusion: Younger, increased PLR and decreased HB were independent risk factors of complicated coronary artery lesion in Kawasaki disease.

参考文献/References:

[1] Newburger J W, Takahashi M, Gerber M A, et al.Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the committee on rheumatic fever, endocarditis and kawasaki disease, council on cardiovascular disease in the young, american heart association[J]. Circulation,2004,110(17):2747
[2] Newburger J W, Takahashi M, Burns J C. Kawasaki disease[J]. J Am Coll Cardiol, 2016,67(14):1738
[3] Ayusawa M, Sonobe T, Uemura S, et al. Revision of diagnostic guidelines for Kawasaki disease (the 5th revised edition)[J]. Pediatr Int, 2005,47(2):232
[4] Group J J. Guidelines for diagnosis and management of cardiovascular sequelae in Kawasaki disease[J]. Pediatr Int, 2010, 47(6):22
[5] Tan T H, Wong K Y, Cheng T K, et al. Coronary normograms and the coronary-aorta index: Objective determinants of coronary artery dilatation[J]. Pediatr Cardiol, 2003,24(4):328
[6] Mccrindle B W, Rowley A H, Newburger J W, et al. Diagnosis, treatment, and Long-Term management of kawasaki disease: a scientific statement for health professionals from the American heart association[J]. Circulation, 2017, 135(17):e927
[7] Makino N, Nakamura Y, Yashiro M, et al. The nationwide epidemiologic survey of Kawasaki disease in Japan, 2015-2016[J]. Pediatr Int, 2019, 61(4):397
[8] 杜忠东，张永兰，林瑶，等.2000-2004年北京小儿川崎病流行病学调查[C]. 中华医学会全国儿科学术会议， 2006
[9] 刘喜.重庆市川崎病流行病学调查研究[D]. 重庆:重庆医科大学，2004
[10] 陈刚，于艳辉，李鹏飞.不完全川崎病的早期诊断[J]. 临床医药文献电子杂志，2017，4(40):7754
[11] Tsai H C, Chang L Y, Lu C Y, et al. Transmission of acute infectious illness among cases of Kawasaki disease and their household members[J]. J Formos Med Assoc, 2015, 114(1):72
[12] 陈晶晶，刘亚黎.Kobayashi评分体系在中国川崎病患儿中的临床应用价值[J]. 华中科技大学学报:医学版，2011，40(6):746
[13] 奚立，桂永浩，盛锋，等.Harada评分预测川崎病冠状动脉病变的临床意义[J]. 临床儿科杂志，2007，25(4):309， 320
[14] 曹亚船.川崎病合并冠状动脉损害高危因素的Meta分析[D].苏州:苏州大学，2014
[15] 余莉，王一斌，乔莉娜，等.川崎病并发冠状动脉损伤的危险因素分析[J]. 中华妇幼临床医学杂志:电子版，2015，11(2):96
[16] 张艺. 川崎病并发冠状动脉损害的危险因素分析[D]. 重庆医科大学儿科学， 2018
[17] 时艳艳，刘芳，吴琳，等.川崎病冠状动脉病变严重程度临床分级及高危因素研究[J]. 中国实用儿科杂志，2014，29(9):681
[18] 吕进泉.川崎病及其冠状动脉损害危险因素的相关研究[D].苏州:苏州大学，2007
[19] 石汝婷，李申堂，杨作成.164例川崎病临床分析[J]. 中国医师杂志，2016，18(6):897
[20] Cicek G, Acikgoz S K, Bozbay M, et al. Neutrophil-Lymphocyte ratio and Platelet-Lymphocyte ratio combination can predict prognosis in patients with ST-Segment elevation myocardial infarction undergoing primary percutaneous coronary intervention[J]. Angiol,2015,66(5):441
[21] 贺威，范继红，靳志涛，等.急性ST段抬高型心肌梗死患者入院早期中性粒细胞/淋巴细胞比值与院内主要不良心血管事件的相关性[J]. 中国循环杂志，2016，31(1):36
[22] Jin P P， Li X M， Chen J， et al. Platelet-to-neutrophil ratio is a prognostic marker for 90-days outcome in acute ischemic stroke[J]. J Clin Neurosci, 2019, 63:110
[23] 李娟.川崎病患儿并发冠状动脉损伤的危险因素探讨及分析[D].济南:山东大学，2017
[24] 陈晶晶.中国川崎病患儿并发冠状动脉损伤的危险程度评分的研究[D]. 武汉:华中科技大学，2011
[25] Nikolsky E, Grines C L, Cox D A, et al. Impact of baseline platelet count. in patients undergoing primary percutaneous coronary intervention in acute myocardial infarction (from the Cadillac trial)[J].Am J Cardiol, 2007,99(8):1055
[26] Acanfora D, Gheorghiade M, Trojano L, et al. Relative lymphocyte count: A prognostic indicator of mortality in elderly patients with congestive heart failure[J]. Am Heart J, 2001,142(1):167
[27] 袁迎第，孙军，李鹏飞，等.中性粒细胞与淋巴细胞比值及血小板与淋巴细胞比值对于川崎病IVIG敏感性的预测价值[J].中国当代儿科杂志，2017，19(4):410
[28] 蔡金秀. 川崎病患儿外周血血小板/淋巴细胞比值、中性粒细胞/淋巴细胞比值变化及临床意义[D]. 重庆医科大学儿科学（心内科）， 2016
[29] 仇慧仙，施红英，何跃娥，等.川崎病延迟治疗冠状动脉损害相关危险因素分析[J]. 温州医科大学学报，2018，48(2):96
[30] 范江花，段蔚，罗海燕，等.血浆N端脑利钠肽前体和降钙素原对早期川崎病冠状动脉损害的预测价值[J].儿科药学杂志，2018，24(9):1
[31] 廖先华，许玉霞，王建军.川崎病患儿血钾和血钠水平的变化及意义[J]. 西部医学，2010，22(9):1652
[32] 卢慧玲，刘亚萍，胡秀芬. N端脑钠肽前体在早期预测川崎病冠状动脉病变中的意义[J]. 中华儿科杂志，2015，53(4):300
[33] Burns J C. Frequently asked questions regarding treatment of Kawasaki disease[J]. Glob Cardiol Sci Pract， 2017， 2017(3):e201730
[34] 乔玉.不同剂量阿司匹林在川崎病急性期治疗疗效的Meta分析[D]. 济南:山东大学，2014
[35] Marchesi A， De Jacobis I T， Rigante D， et al. Kawasaki disease: guidelines of Italian Society of Pediatrics， part II-treatment of resistant forms and cardiovascular complications， follow-up， lifestyle and prevention of cardiovascular risks[J]. Ital J Pediatr， 2018，44(1):103
[36] 盛丹丽.糖皮质激素治疗KD冠脉损害的Meta分析及冠脉损伤危险因素分析[D]. 济南:山东大学，2015
[37] 赵冬梅，尹千里，季雪红，等.肾上腺糖皮质激素联合乌司他丁治疗儿童川崎病的非随机对照临床研究[J].中国当代儿科杂志，2015，17(8):780
[38] 胡景伟，周忠蜀，杨凌，等.糖皮质激素联合静脉免疫球蛋白治疗川崎病有效性和安全性的荟萃分析[J].中华医学杂志，2011， 91(18):1259

相似文献/References:

[1]王晓晓,周宇辉,王 倩,等.氨基末端脑钠肽前体水平对丙种球蛋白无反应性川崎病的预测价值[J].天津医科大学学报,2016,22(06):502.
　WANG Xiao-xiao,ZHOU Yu-hui,WANG Qian,et al.Predictive value of plasma brain natriuretic peptide in IVIG-resistant Kawasaki disease[J].Journal of Tianjin Medical University,2016,22(01):502.
[2]韩飞 综述,刘力 审校.血清Ｎ末端Ｂ型利钠肽在识别川崎病冠状动脉损伤中的研究进展[J].天津医科大学学报,2021,27(02):208.
[3]贾丽娟,吕爱婷,冯迎军,等.KD患儿急性期h-FABP、PAC-1表达与冠状动脉受损的关系[J].天津医科大学学报,2021,27(04):334.
　JIA Li-juan,Lyu Ai-ting,FENG Ying-jun,et al.Relationship between expression of h-FABP and PAC-1 and coronary artery damage in children with KD in acute phase[J].Journal of Tianjin Medical University,2021,27(01):334.

备注/Memo

备注/Memo:

作者简介 王茜（1993-），女，硕士，研究方向：儿科学；通信作者：郑荣秀，E-mail：18622815720@163.com。

常用功能

更新日期/Last Update: 2020-04-16